Curia, formerly AMRI, a contract research, development and manufacturing organization, has entered into a definitive agreement to acquire Integrity Bio, Inc., a privately held formulation and fill-finish company headquartered in Camarillo, CA. The transaction, subject to customary closing conditions, is expected to close in the third quarter. Financial details were not disclosed. Integrity Bio has expertise in hard-to-formulate biologics and fill-finish of unique therapies in preclinical a...